Observed arrival · 2026-10-31
EVOQ Bio’s antimicrobial metamaterial
EVOQ Bio presents EVQ-218, a non-ionic silver metamaterial being developed for antimicrobial use in medical devices and therapeutics.
- For
- Medical-device and therapeutic-development teams
- Worth noticing
- The page says a Cystic Fibrosis Foundation-funded study used CLSI methods; it also states all efficacy data to date is preclinical.
Field notes
The page describes EVQ-218 as a non-ionic silver metamaterial and says a Cystic Fibrosis Foundation-funded study at Seattle Children's Research Institute assessed 64+ bacterial, fungal, and mycobacterial isolates using CLSI methods. It reports bactericidal classification under assay conditions and no MIC elevation after 30 serial passages across six ESKAPE pathogens. The proposed Silver-Sulfur Siege mechanism is presented as a hypothesis; the site says efficacy evidence remains preclinical and implies no therapeutic or device approval.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
One card from the complete issue